Astrazeneca Plc (AZN)
$53.11
2.11 (3.82%)
AZN Stock Quote Delayed 30 Minutes
Previous Close
$53.11
Market Cap
134.54B
PE Ratio
47.94
EPS
1.107848
Volume (Avg. Vol.)
5.63M
Day's Range
53.10 - 54.59
52-Week Range
36.15 - 57.44
Dividend & Yield
1.37 (2.58%)
AZN Stock Predictions, Articles, and Astrazeneca Plc News
AstraZeneca (AZN) Upgraded to Buy from a Hold
AstraZeneca Plc (NYSE:AZN) is ranked as a Buy using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methods. The shares have been upgraded from a Hold to a Buy in the last week.
Earnings Growth Restricts AstraZeneca (AZN) Rating
Portfolio Grader currently ranks AstraZeneca Plc (NYSE:AZN) a Hold. Using Louis Navellier's investing methodology, this analytical tool assesses stocks with fundamental and quantitative analytical tools. AZN has maintained this ranking for the last month.
Quant Score Restricts AstraZeneca (AZN) Rating
AstraZeneca Plc (NYSE:AZN) is a component of the 135 company Pharmaceuticals GICS industry group, which is a segment of the 783 company GICS Health Care sector. AZN's market value is $87.6 billion which falls in the top decile in its industry group. The ranking for AZN by Portfolio Grader places it 49 among the 135 companies in this industry group, placing it in the top half; in the top half of the sector with a ranking of 301 among the 783 companies in the sector, and number 2,076 in the nearly 5,000 company Portfolio Grader universe.
Hold Rating for AstraZeneca (AZN) Retained
Portfolio Grader currently ranks AstraZeneca Plc (NYSE:AZN) a Hold. With exclusive fundamental and quantitative analytical tools developed by Louis Navellier, this analytical tool evaluates nearly 5,000 stocks weekly. The current Portfolio Grader recommendation on the shares has been in place for the last month.
AstraZeneca’s (AZN) Stock Has Sell Ranking Reaffirmed
Currently, AstraZeneca Plc (NYSE:AZN) has a Sell using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. AZN has maintained this ranking for 2 months.
Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Intrepid Potash, Inc. (IPI) and Marathon Oil Corporation (MRO) Are 3 of Today’s Worst Stocks
Marathon Oil (MRO), Teva Pharmaceutical Industries (TEVA) and Intrepid Potash (IPI) shareholders should have made it a three-day weekend.
Will Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Catch a Break?
TEVA stock is in the spotlight again when it reports quarterly results this week. Teva Pharmaceutical investors will look closely at cash flow and debt.
Why AstraZeneca plc (ADR) (AZN), Advanced Micro Devices, Inc. (AMD) and Spirit Airlines Incorporated (SAVE) Are 3 of Today’s Worst Stocks
Advanced Micro Devices (AMD), AstraZeneca (AZN) and Spirit Airlines (SAVE) never even had a prayer of bullish progress on Thursday.
Why Bristol-Myers Squibb Co (BMY) Shares Are Sinking Today
Bristol-Myers Squibb (BMY) stock took a hit today after AstraZeneca (AZN) reported a failed drug test, despite its positive earnings report.
AstraZeneca plc (ADR) (AZN) Stock Tanks on Lung Cancer Drug Disappointment
AstraZeneca(AZN) stock was hit hard Thursday after its new lung cancer drug failed to meet a primary endpoint in a Phase III trial.
Why Cyberark Software Ltd (CYBR), Teva Pharmaceutical Industries Ltd (ADR) (TEVA) and Wynn Resorts, Limited (WYNN) Are 3 of Today’s Worst Stocks
Teva Pharmaceutical (TEVA), Wynn Resorts (WYNN) and Cyberark Software (CYBR) shareholders couldn't wait for the trading week to end.
AstraZeneca plc (ADR) (AZN) Shares Soar on Lung Cancer Drug Success
AstraZeneca (AZN) stock was up on Friday following positive results in a Phase III trial for its lung cancer drug Imfinzi.
3 Big Charts for Friday: Tiffany & Co. (TIF), J C Penney Company Inc (JCP) and AstraZeneca plc (ADR) (AZN)
JC Penney (JCP) stock dips into technical no-man's land, while Tiffany (TIF) and AstraZeneca (AZN) are attracting technical buyers.
Valeant Pharmaceuticals Intl Inc (VRX) Stock Won’t Keep This Rally Up
Valeant earnings are due out Tuesday morning, but it would take a laundry list of good news to sustain the rally in VRX stock.
5 Reasons Why Sanofi SA (ADR) (SNY) is a Good Stock to Buy Now
Paris, France based Sanofi (SNY) is a global healthcare company possessing a diversified product portfolio.
Why Tesaro Inc (TSRO) Stock Roared, Then Reversed
Tesaro (TSRO) climbed Tuesday on an FDA approval, but possible side effects and lack of price info have dampened the parade in TSRO stock.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
A
